Literature DB >> 9714209

Location of induction and expression of protective immunity against Fasciola hepatica at the gut level: a study using an ex vivo infection model with ligated gut segments.

F J van Milligen1, J B Cornelissen, B A Bokhout.   

Abstract

In the present study, we investigated the site in the host where protective gut immunity to Fasciola hepatica is induced and expressed, following the infection route of the parasite. Expression of protection was studied in ex vivo gut segments with intact blood and lymph supply that were prepared at different locations along the entire length of the small and large intestine. Four weeks after oral infection, significant protection was detected in the duodenum, upper jejunum, midjejunum, and ileum. Protection at the gut level was expressed as early as 2 wk after oral priming and waned after 27 wk. The possibility that the gut wall plays a role in age-related protection was excluded. The effect of newly excysted juveniles (NEJ) penetrating the gut on the induction of protection was studied by recovering or killing the NEJs of the primary infection immediately after gut migration. Results showed that protection was low (13.9-19.8%). However, when gut migration was by-passed and NEJs of the primary infection were injected into the peritoneal cavity or between the liver lobes, high levels of protection at the gut level were detected (76.5-87.4%). The results indicate that protection expressed at the gut level is induced by the parasite at a young stage, during migration through the peritoneal cavity, or liver, or both and not during penetration of the gut.

Entities:  

Mesh:

Year:  1998        PMID: 9714209

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  5 in total

1.  Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica.

Authors:  David Piedrafita; Endah Estuningsih; Jill Pleasance; Rhoda Prowse; Herman W Raadsma; Els N T Meeusen; Terry W Spithill
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

2.  Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.

Authors:  Malgorzata Kesik-Brodacka; Agnieszka Lipiec; Monika Kozak Ljunggren; Luiza Jedlina; Katarzyna Miedzinska; Magdalena Mikolajczak; Andrzej Plucienniczak; Andrzej B Legocki; Halina Wedrychowicz
Journal:  PLoS Negl Trop Dis       Date:  2017-03-23

3.  Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.

Authors:  M Adela Valero; Ignacio Perez-Crespo; Carlos Chillón-Marinas; Messaoud Khoubbane; Carla Quesada; Marta Reguera-Gomez; Santiago Mas-Coma; Manuel Fresno; Núria Gironès
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

4.  Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola Gigantica that cause the zoonosis Fasciolosis.

Authors:  Richard Lalor; Krystyna Cwiklinski; Nichola Eliza Davies Calvani; Amber Dorey; Siobhán Hamon; Jesús López Corrales; John Pius Dalton; Carolina De Marco Verissimo
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 5.  A prospective view of animal and human Fasciolosis.

Authors:  K Cwiklinski; S M O'Neill; S Donnelly; J P Dalton
Journal:  Parasite Immunol       Date:  2016-07-08       Impact factor: 2.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.